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Multidrug-resistant tuberculosis was diagnosed in 21
HIV-negative, nonhospitalized male patients residing in
northern Tunisia. A detailed investigation showed acceler-
ated transmission of a Mycobacterium tuberculosis clone of
the Haarlem type in 90% of all patients. This finding high-
lights the epidemic potential of this prevalent genotype.
T
he ability of multidrug-resistant (MDR) strains of
Mycobacterium tuberculosis to cause epidemics and
spread globally contrasts with the initial perception that
MDR tuberculosis (MDR-TB) has a reduced potential for
transmission (1,2). In this respect, the W/Beijing type
appears to be most common in humans and accounts for
most reported MDR-TB outbreaks (3).
In this report, we provide evidence for the epidemic
potential of another worldwide prevalent M. tuberculosis
genotype, namely, the Haarlem family (4,5). The identified
strain is MDR and has rapidly expanded within immuno-
competent and nonhospitalized patients. 
The Study
M. tuberculosis isolates were obtained from the
Laboratory of Mycobacteriology of the Institut Pasteur de
Tunis as part of the National Tuberculosis Surveillance
Program. All samples (884 specimens) from patients with
suspected TB residing in northern Tunisia (Bizerte) from
August 2001 to October 2003 were forwarded to us by the
referral regional hospital. This hospital serves a region
with 483,086 people and an area of 3,501 km2. The inci-
dence of TB in this area from 2001 to 2002 was
29/100,000 male patients and 11/100,000 female patients.
All patients received the standard chemotherapy regimen
of the Tunisian National Tuberculosis Program, i.e., 2
months of rifampicin, isoniazid, pyrazinamide, and strep-
tomycin, followed by 4 months of rifampicin and isoniazid
(2RHZS/4RH). This regimen was introduced into the
region in 1995. Of the 193 M. tuberculosis isolates recov-
ered, 20 were MDR. The corresponding patients were
interviewed, and detailed epidemiologic investigations
were conducted according to described protocols (6). In
April 2004, while the study was in progress, a new MDR
case was diagnosed.
Analyses by IS6110 restriction fragment length poly-
morphism (IS6110 RFLP), ligation-mediated polymerase
chain reaction (PCR), and spoligotyping were carried out
by using standard protocols (7–9). Typing of the polymor-
phic GC-rich repetitive sequence (PGRS) with probe
MTB484 (1) was conducted according to a previously
reported protocol (10), with the exception that DNA was
digested with AluI. Isolates were assigned to principal
genetic groups according to the polymorphisms in the katG
and gyrA genes (11). The following primer pairs were used
to sequence rpoB, katG, and pncA gene mutations that con-
fer resistance to rifampicin, isoniazid, and pyrazinamide,
respectively:  rpoB (5′-ATCACACCGCAGACGTTG-3′,
5′-TGCATCACAGTGATGTAGTCG-3′); katG (5′- CGT-
CGAAACAGCGGCGCTGA-3′, 5′-CAAGCGCCAGC-
AGGGCTCTT-3′); and pncA (5′-GGCGCACACAA-
TGATCGGTG-3′, 5′-GCTTTGCGGCGAGCGCTCCA-
3′). The recently described single nucleotide polymor-
phisms in putative M. tuberculosis mutator genes mutT1,
mutT2, mutT3, and ogt were investigated with the same
protocol reported by Rad et al. (12). DNA sequencing was
conducted directly on the purified PCR products by using
the Prism Ready Reaction Dye Deoxy Terminator Cycle
sequencing kit on an ABI Prism 377 DNA sequencer
(Applied Biosystems, Foster City, CA, USA).
Epidemiologic and clinical data indicated that all
patients with MDR-TB were male with a mean age of 31
years at diagnosis (Table 1). All were Tunisians and per-
manently resided in the northern part of the country
(Bizerte). All patients were seronegative for HIV with no
documented history of travel abroad, and none had a histo-
ry of immunosuppression, diabetes, or respiratory diseases
other than TB. Mapping of the 21 patients with MDR-TB
according to their residence sites showed that they were
mostly scattered over the northeastern part of the region
(surface area ≈1,000 km2) with no concentration in a par-
ticular locality (data not shown). Resistance to 5 first-line
drugs was observed for most isolates (Table 2). 
As indicated in Table 1, with the exception of patient
P20, the DNAsamples subjected to molecular typing were
obtained from the initial isolate of all new patients. RFLP
showed that 18 patients had nearly identical IS6110 pro-
files (Figures 1 and 2). The predominant profile (occurring
in 13 patients) showed 11 bands, while the remaining
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absence of the additional IS6110 band was not restricted to
new or previously treated patients. The RFLP pattern of
patient P11, a new patient, clearly showed a mixture of the
12-band profile and some additional IS6110 bands (Figure
2A). Typing of his follow-up culture, which was obtained
after 6 months of directly observed short-course therapy,
as recommended by the World Health Organization, yield-
ed only the 12-band profile (Figure 2A). Laboratory
records and epidemiologic data indicate that this patient
likely had a dual infection.
The isolate from patient P13 was typed by ligation-
mediated PCR. Its profile was identical to the 18 other
MDR isolates. Thus 19 patients with MDR-TB could be
clustered according to IS6110-based typing. Effective epi-
demiologic links were identified for 9 (47%) patients
(Table 1). Another similar RFLP pattern was observed for
patient P20. It shows 10 IS6110 bands (Figure 2B), 9 of
which are common to the 12-band RFLP pattern described
for the other isolates. The isolate from patient P19 dis-
played a 9-band IS6110 profile that was clearly distinct
from all the other patients with MDR-TB (data not shown).
With the exception of patient P19, the MDR isolates
were identical in their PGRS profile (Figure 2) and spolig-
otype patterns (Table 2), which is characteristic of the
Haarlem3 type (4). Sequence analysis of mutator and drug
resistance genes conclusively confirmed that the 19 MDR
isolates with nearly identical IS6110 (both 12- and 11-band
profiles) are genetically closely related. They all harbor the
L209L, T15S, S531L, and S315T mutations in mutT3, ogt,
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mutT1 and MutT2 showed a wild type genotype (data not
shown). The occurrence of an additional uncommon muta-
tion in the rpoB gene (V610M) confirmed the clonality of
this MDR Haarlem strain since it was present only in 19
patients with MDR-TB. The variability of resistance to
pyrazinamide and the mutational profile within the pncA
gene (Table 2) strongly suggest that primary transmission
from person to person occurred mainly with a strain that
was simultaneously resistant to isoniazid and rifampicin. 
To extend our analysis of the situation that prevailed in
this region, samples from 143 (83%) of 172 patients with-
out MDR strains were spoligotyped. Of these 143 patients,
41 (29%) were female. Overall, 31 (22%) of the 143
patients had Haarlem3 genotype TB. In contrast to the
MDR-TB outbreak that involved only men, 6 women had
a non-MDR Haarlem3 strain. Aside from the absence of
clustering, ligation-mediated PCR typing showed that
none of these non-MDR Haarlem3 isolates displayed a
profile similar to the 19 MDR isolates involved in the
transmission chain. Sequencing of the rpoB gene of 10 iso-
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Figure 1. IS6110 restriction fragment length polymorphism (RFLP)
analysis of Mycobacterium tuberculosis isolates from 16 patients
associated with the multidrug-resistant tuberculosis outbreak,
Bizerte, Tunisia, 2001–2004. Lane M, reference strain MTB14323.
Values above each well correspond to each patient as identified in
Table 1. Values on the left are in kilobases.lates randomly selected from the 31 non-MDR Haarlem
isolates showed the absence of the outbreak-associated
mutation V610M. This finding is strongly indicative of a
true clonal expansion and a typical MDR-TB outbreak.
The W/Beijing type was absent in the analyzed pool of iso-
lates.
Conclusions
The results indicate that an MDR strain of M. tubercu-
losis has been actively transmitted among 19 HIV-negative
male patients in Tunisia. Several observations indicate that
this particular Haarlem strain displays increased transmis-
sibility, virulence, or both. First, the outbreak peaked sud-
denly within a relatively short period of 21 months; 17 new
cases (89%) were reported from September 2001 to June
2003. Inspection of the hospital register for 2000 showed
only 3 new patients with MDR isolates, including out-
break-associated patients P5 and P7 (Table 1). Second, no
epidemiologic links or contact points could be traced for
several patients, which suggests that brief exposure would
have been sufficient for effective transmission. Because
patients with MDR-TB do not respond to treatment, they
may serve as constant sources of transmission. Such a sit-
uation is likely to have occurred for the patients with estab-
lished epidemiologic links. Third, the incidence of TB in
the region in which the outbreak occurred is not particular-
ly high. Fourth, patients were seronegative for HIV with
no history of treatment causing immunosuppression. Fifth,
no AIDS-associated TB outbreak that might have
increased the adaptability of the strain within the indige-
nous population had occurred in the region. Sixth,
although the Haarlem strain was MDR, it was able to cause
an outbreak in those vaccinated with bacille Calmette-
Guérin and in persons who were not hospitalized. 
Among the identified M. tuberculosis strain families
(4,5), the W/Beijing type has been associated with out-
breaks or microepidemics worldwide (3). The Haarlem
strain family appears to be widespread (4), but its ability to
cause outbreaks has been reported only twice, once in
Argentina (13) and once in the Czech Republic (14). The
distinctive feature of the present Haarlem MDR-TB out-
break is its accelerated transmission compared with the
first 2 MDR-TB outbreaks.
Alterations within DNA repair genes (mutator genes)
are thought to favor the emergence of MDR strains with an
increased adaptability (12). In this respect, both W/Beijing
and Haarlem strains accumulated mutations within their
putative mutator genes. Widespread MDR strains might
also benefit from their intrinsic adaptability (15). From an
epidemiologic point of view, TB programs must conduct
extensive surveillance of MDR strains of M. tuberculosis
strain families because they might cause serious outbreaks.
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